Shayna T. J. Bradford

Shayna T. J. Bradford

Auto-generated profile, based on publicly available information

Shayna T. J. Bradford

Division of Nephrology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri, United States

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
SBShayna T. Bradford
Shayna T. Bradford
SSSvetlana M. Stamatovic
Svetlana M. Stamatovic
RDRaj S. Dondeti
Raj S. Dondeti
RKRichard F. Keep
Richard F. Keep
AAAnuska V. Andjelkovic
Anuska V. Andjelkovic
A substantial body of evidence suggests that nicotine adversely affects cerebral blood flow and the blood-brain barrier and is a risk factor for stroke. The present study investigated the effect of nicotine on cerebrovascular endothelium under basal and ischemia/reperfusion injury under in vivo condition. Nicotine (2 mg/kg sc) was administered to mice over 14 days, which resulted in plasma nicotine levels of ∼100 ng/ml, reflecting plasma concentrations in average to heavy smokers. An analysis of the phenotype of isolated brain microvessels after nicotine exposure indicated higher expression of inflammatory mediators, cytokines (IL-1β, TNF-α, and IL-18), chemokines (CCL2 and CX3CL1), and adhesion molecules (ICAM-1, VCAM-1, and P-selectins), and this was accompanied by enhanced leukocyte infiltration into brain during ischemia/reperfusion ( P < 0.01). Nicotine had a profound effect on ischemia/reperfusion injury; i.e., increased brain infarct size ( P < 0.01), worse neurological deficits, and a higher mortality rate. These experiments illuminate, for the first time, how nicotine regulates brain endothelial cell phenotype and postischemic inflammatory response at the brain-vascular interface.

1 March 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SBShayna T. J. Bradford
Shayna T. J. Bradford
EREgon J. Ranghini
Egon J. Ranghini
EGEdward Grimley
Edward Grimley
PLPil H. Lee
Pil H. Lee
GDGregory R. Dressler
Gregory R. Dressler
Bone morphogenetic protein (BMP) signaling is critical in renal development and disease. In animal models of chronic kidney disease (CKD), re-activation of BMP signaling is reported to be protective by promoting renal repair and regeneration. Clinical use of recombinant BMPs, however, requires harmful doses to achieve efficacy and are costly because of BMPs complex synthesis. Therefore, alternative strategies are needed to harness the beneficial effects of BMP signaling in CKD. Key aspects of the BMP signaling pathway can be regulated by both extracellular and intracellular molecules. In particular, secreted proteins like Noggin and Chordin inhibit BMP activity, whereas Kielin/Chordin-like proteins (KCP) enhance it and attenuate kidney fibrosis or CKD. Clinical development of KCP, however, is precluded by its size and complexity. Therefore, we propose an alternative strategy to enhance BMP signaling by using small-molecules, which are simpler to synthesize and more cost-effective. To address our objective, here we developed a small-molecule high-throughput screen (HTS) with human renal cells having an integrated luciferase construct highly responsive to BMPs. We demonstrate the activity of a potent benzoxazole compound, sb4, that rapidly stimulated BMP signaling in these cells. Activation of BMP signaling by sb4 increased the phosphorylation of key second messengers (SMADs-1/5/9) and also increased expression of direct target genes (inhibitors of DNA binding, ID1 and ID3) in canonical BMP signaling. Our results underscore the feasibility of utilizing HTS to identify compounds that mimic key downstream events of BMP signaling in renal cells and yielded a lead BMP agonist.

1 May 2024 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
SBShayna T. J. Bradford
Shayna T. J. Bradford
HWHaojia Wu
Haojia Wu
YKYuhei Kirita
Yuhei Kirita
CCChangfeng Chen
Changfeng Chen
NMNicole P. Malvin
Nicole P. Malvin
BHBenjamin D. Humphreys
Benjamin D. Humphreys
The molecular drivers of successful and failed repair in the proximal tubule after acute kidney injury (AKI) are incompletely understood. We identified Traf2 and Nck interacting kinase ( Tnik) to be exclusively expressed in failed-repair proximal tubule cells after AKI. We tested the effect of si TNIK depletion in two proximal tubule cell lines followed by bulk RNA-sequencing analysis. Our results indicate that TNIK acts to suppress inflammatory signaling and apoptosis in injured renal proximal tubule epithelial cells to promote cell survival.

1 March 2022 in Cell Chemical Biology
Verified
Journal Article
Closed access
SBShayna T.J. Bradford
Shayna T.J. Bradford
EGEdward Grimley
Edward Grimley
ALAnn M. Laszczyk
Ann M. Laszczyk
PLPil H. Lee
Pil H. Lee
SPSanjeevkumar R. Patel
Sanjeevkumar R. Patel
GDGregory R. Dressler
Gregory R. Dressler

1 June 2003 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PDF file
SBShayna T.J. Bradford
Shayna T.J. Bradford
KGKimberly Golden
Kimberly Golden
JFJohn M. Flack
John M. Flack
RCRosie Calvin
Rosie Calvin
HTHerman A. Taylor
Herman A. Taylor
ECErrol D. Crook
Errol D. Crook